Drug
Spn 538
Spn 538: highest development phase Post-Market, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPN-538 NCT04050293 | Post-Market | Migraine Disorders |
Latest
No recent events.
Follow Spn 538 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.